But the design faces an uphill climb in the halls of the Pentagon, military experts said. Russia's war in Ukraine has shown the promise and peril of tank technology in a modern battlefield. Military strategists worry how useful tanks might be in a potential war against China, the U.S. military's chief rival. Outfitting lethal machines with artificial intelligence also concerns military skeptics.

Artificial intelligence can make drug discovery and development faster and less risky according to an industry expert, who said understanding complex diseases at the genetic level is now a possibility. Data has always been key to drug development. Pharmaceutical products are approved based on empirical evidence of safety and efficacy that is generated in preclinical experiments and clinical trials. Data is also core to the discovery process, with developers selecting candidates that have shown through experimentation that they interact with their chosen disease targets. In recent years, the way data is used for drug discovery and development has changed.

What if we could generate novel molecules to target any disease, overnight, ready for clinical trials? Imagine leveraging machine learning to accomplish with 50 people what the pharmaceutical industry can barely do with an army of 5,000. It's a multibillion-dollar opportunity that can help billions. The worldwide pharmaceutical market, one of the slowest monolithic industries to adapt, surpassed $1.1 trillion in 2016. In 2018, the top 10 pharmaceutical companies alone are projected to generate over $355 billion in revenue.

What if we could generate novel molecules to target any disease, overnight, ready for clinical trials? Imagine leveraging machine learning to accomplish with 50 people what the pharmaceutical industry can barely do with an army of 5,000. It's a multibillion-dollar opportunity that can help billions. The worldwide pharmaceutical market, one of the slowest monolithic industries to adapt, surpassed $1.1 trillion in 2016. In 2018, the top 10 pharmaceutical companies alone are projected to generate over $355 billion in revenue.

The maker of the world's most deadly firearm has unveiled plans for a radical AI controlled gun for the Russian military. Kalashnikov, best known for its AK-47 rifle, is building'a range of products based on neural networks,' including a'fully automated combat module' that can identify and shoot at its targets. The new products were revealed in an interview with Kalashnikov spokeswoman Sofiya Ivanova by TASS, a Russian government information agency. The Kalashnikov'combat module' will consist of a gun connected to a console that constantly analyses image data to identify targets. According to Kalashnikov it will be able to'make decisions' on whether to shoot.